Skip to Content
Stock Analyst Update

Strong Q1 for AB InBev, Beating Revenue Estimates

We have pulled forward our recovery expectations and make no change to our fair value estimate or our wide economic moat rating.

Mentioned: ,

Anheuser-Busch InBev (BUD) (ABI) reported a strong first quarter that beat our estimates on volume and revenue. Margins fell slightly year over year, in line with guidance, but this does not detract from what was a good quarter overall. The president of AB InBev's North America zone, Michel Doukeris, will replace Carlos Brito as CEO on July 1. We have pulled forward our recovery expectations and make no change to our $90 fair value estimate or our wide economic moat rating. Although the shares have recovered somewhat since full-year 2020 results were reported, we still see upside and think margin expansion next year could reassure investors that deleveraging will continue organically.

First-quarter volume grew 13.3% on an organic basis. This was well ahead of our estimate of an 8% increase, and we think this reflects pent-up demand in the on-trade in markets that have been coming out of lockdown restrictions. The upside to our estimates was driven by Asia-Pacific volume, up a stunning 64.1%, and Middle Americas volume, up 12.2%. This is consistent with global competitors Carlsberg and Heineken, which both reported strong volume growth in Asia, as China emerged from the lockdown measures that annihilated volume in the first quarter last year. We have probably underestimated the strength of the pent-up demand, and we now assume that as markets open back up, demand will snap back quickly. However, we still believe that it is likely to be next year before prepandemic trends resume, as we expect a small proportion of the on-trade to have gone out of business during the lockdown period.

A key question for all consumer product companies this year, and AB InBev in particular, is margin development. Raw material costs are likely to rise for most manufacturers, and AB InBev clearly saw some inflation, as the gross margin fell 122 basis points despite positive price/mix. This was offset by operating leverage from higher volume.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

Philip Gorham does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.